Check out what we’ve been up to and where can we connect!
October 16, 2020
Development and ongoing activities of the China Tuberculosis Clinical Trials Consortium (CTCTC) were described in an article published in the Infectious Diseases of Poverty journal earlier this year. Read more, including FHI Clinical’s role in providing the network with technical support and guidance for clinical trial capacity building.
October 12, 2020
Oracle Health Sciences and FHI Clinical Inc. have joined efforts to improve clinical trial efficiency and help get therapies to market faster. FHI Clinical has adopted Oracle Health Sciences Clinical One for randomization, supply management, and data collection; Oracle Argus Safety for safety case management; Oracle CTMS Cloud Service to manage the entire research portfolio; and Oracle ClearTrial Cloud Service to help budget, plan and bid on projects.
October 8, 2020
Final results of the Adaptive COVID-19 Treatment Trial (ACTT)-1 investigating remdesivir for the treatment of COVID-19 in hospitalized adults with evidence of lower respiratory tract involvement have been published in the New England Journal of Medicine (NEJM). Of the FHI Clinical study team members, Danielle Fisher, Clinical Research Project Manager, and Wendi McDonald, Associate Project Manager, are listed on the manuscript for their contributions to the study.
September 16, 2020
The operational goal is to provide experienced oversight while advancing the Partnership for Research on Vaccines and Infectious Diseases in Liberia (PREVAIL) network toward long-term, local self-sustainability – to conduct high-quality research with a focus on emergent and high-impact public health research priorities in Liberia.
April 29, 2021
Biomedical researchers, clinical research organizations, people infected and impacted by the pandemic, along with Black barbers and stylists, will come together in a virtual event April 29 at 6 p.m. to provide straight talk about fears, trust issues, and why we need our Black and Brown community to be part of COVID-19 vaccine research.
April 20-22, 2021
Attending the Global Forum on TB Vaccines? Visit our booth to learn more about our services or schedule a meeting with our team.
April 21, 2021
Join us for this panel discussion in which experts in infectious diseases will discuss the effect of WHO recommendations around TPT for individuals at high risk of TB infection and increased TPT use on TB vaccine development.
March 26, 2021
Bring all your questions about things like vaccine hesitancy, equitable vaccine distribution and other issues facing the black community to “Colors of COVID-19 Barber Shop and Salon Talk.”
November 15-19, 2020
Attending the ASTMH 2020 Annual Meeting? Schedule a meeting with an FHI Clinical team member who will be in attendance at the event or stop by our booth
November 5-8, 2020
Attending WOCIP? Tafoya Hubbard and LaTonya Jones from FHI Clinical will be attending and would love to hear about your experiences in the pharmaceutical industry.
FHI Clinical Headquarters
359 Blackwell Street, Suite 200
Durham, NC 27701 USA